Order Article Reprints

Wu X, Li J, Zhou L, Chen J, Jin Z, Meng Q, Chai J, Gao H, Wang Y, Zhao D, et al. A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures. Vaccines. 2023; 11(8):1311. https://doi.org/10.3390/vaccines11081311

Wu, Xiaohong, Jia Li, Lei Zhou, Jianmin Chen, Zhongqiang Jin, Qingwei Meng, Jing Chai, Hongxia Gao, Yunpeng Wang, Danhua Zhao, and et al. 2023. "A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures" Vaccines 11, no. 8: 1311. https://doi.org/10.3390/vaccines11081311

Wu, X., Li, J., Zhou, L., Chen, J., Jin, Z., Meng, Q., Chai, J., Gao, H., Wang, Y., Zhao, D., Wu, H., Yu, J., Chen, N., Wang, Y., Lin, Y., Huang, P., Li, Y., & Zhang, Y. (2023). A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10–60 Years Following Essen and Zagreb Vaccination Procedures. Vaccines, 11(8), 1311. https://doi.org/10.3390/vaccines11081311